NCT02359357View on ClinicalTrials.gov

FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

FDL169

DRUG

Placebo

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

All Listed Sponsors
lead

Flatley Discovery Lab LLC

OTHER

NCT02359357 - FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers | Biotech Hunter | Biotech Hunter